Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Queensland Health
Merck
US Army
Mallinckrodt
Daiichi Sankyo
Boehringer Ingelheim
Dow
Cerilliant

Generated: February 19, 2018

DrugPatentWatch Database Preview

Aurobindo Company Profile

« Back to Dashboard

What is the competitive landscape for AUROBINDO, and what generic and branded alternatives to AUROBINDO drugs are available?

AUROBINDO has three hundred and fourteen approved drugs.

There are thirty-five tentative approvals on AUROBINDO drugs.

Summary for Aurobindo
US Patents:0
Tradenames:241
Ingredients:217
NDAs:314

Drugs and US Patents for Aurobindo

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd IRBESARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; irbesartan TABLET;ORAL 203630-001 Feb 22, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 065395-001 Aug 8, 2008 DISCN No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065505-001 Jul 31, 2008 DISCN No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd NAPROXEN naproxen TABLET;ORAL 200429-002 Nov 8, 2011 AB RX No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd ESCITALOPRAM OXALATE escitalopram oxalate SOLUTION;ORAL 079062-001 Apr 2, 2012 AA RX No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 090432-003 Sep 11, 2012 AB RX No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd METRONIDAZOLE metronidazole TABLET;ORAL 203974-001 May 29, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma MELOXICAM meloxicam TABLET;ORAL 078008-001 Oct 2, 2006 AB RX No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 203062-002 Jul 1, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Aurobindo Pharma RISPERIDONE risperidone TABLET;ORAL 078269-006 Oct 8, 2008 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for AUROBINDO drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 6/3/2015
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Deloitte
Queensland Health
McKesson
Express Scripts
US Army
Boehringer Ingelheim
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot